Skip to main content

Table 3 Distribution of virulence genes according to antibiotic susceptibility among 120 Escherichia coli isolated from urinary tract infection

From: Characterization of Escherichia coli isolated from urinary tract infection and association between virulence expression and antimicrobial susceptibility

Antibiotics

Prevalence of pap (%) in

Prevalence of hlyA (%) in

Prevalence of cnf (%) in

bSus. isolates

Res. isolates

Sus. isolates

Res. isolates

Sus. isolates

Res. isolates

CIP (naā€‰=ā€‰40)

35

31.2

35

15*

22.5

15

TS (nā€‰=ā€‰34)

29.4

33.7

26.5

19.8

11.8

19.8

GM (nā€‰=ā€‰62)

32.3

32.8

17.7

25.9

16.1

19

Cax (nā€‰=ā€‰66)

33.3

31.5

28.8

13*

19.7

14.8

TE (nā€‰=ā€‰49)

30.6

33.8

28.6

16.9

18.4

16.9

NX (nā€‰=ā€‰74)

32.4

32.6

24.3

17.4

16.2

19.6

Caz (nā€‰=ā€‰77)

35.1

27.9

27.3

11.6*

22.1

9.3

NA (nā€‰=ā€‰53)

32.1

32.8

26.4

17.9

22.6

13.4

AK (nā€‰=ā€‰89)

29.2

41.9

22.5

19.4

13.5

29

Cpe (nā€‰=ā€‰55)

34.5

30.8

30.9

13.8*

23.6

12.3

Azt (nā€‰=ā€‰74)

33.8

30.4

25.7

15.2

20.3

13

  1. Abbreviation: CIP Ciprofloxacin, TS Trimethoprim-sulfamethoxazole, GM Gentamicin, Cax Ceftriaxone, TE Tetracycline, NX Norfloxacin, Caz Ceftazidime, NA Nalidixic acid, AK Amikacin, Cpe Cefepime, Azt Aztreonam
  2. anā€‰=ā€‰Number of susceptible isolates to the antibiotic
  3. bSus. Susceptible, Res. Resistant
  4. *Comparison yielded a P value ofā€‰<ā€‰0.05